BG Medicine Inc. (OTCMKTS:BGMD – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.00 and traded as high as $0.0001. BG Medicine shares last traded at $0.0001, with a volume of 16,750 shares.
BG Medicine Price Performance
BG Medicine Company Profile
BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.
Further Reading
- Five stocks we like better than BG Medicine
- What does consumer price index measure?
- Whirlpool’s Worst May Be Over—Upside Opportunity Ahead
- What is a Secondary Public Offering? What Investors Need to Know
- These 3 Beaten-Down Stocks Could Be Your Best Buying Opportunity This Quarter
- What is a penny stock? A comprehensive guide
- How Does D-Wave Stack Up to Quantum Rivals After Earnings Season?
Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
